Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Syntaxin-12 (STX12) is a member of the syntaxin family of SNARE proteins that mediates vesicle docking and fusion within intracellular compartments, particularly the early endosomes[3][4][5]. It is a type II transmembrane protein localized mainly to endosomal membranes and is involved in the fusion and recycling of endosomes and surface proteins[4]. Together with SNARE partners such as STX6, syntaxin-12 promotes trafficking from endosomes to the plasma membrane and is essential for the organization of the endocytic pathway and recycling of cellular components[4]. SNARE proteins, including syntaxin-12, are crucial for specificity in vesicular fusion, facilitating tightly regulated exo- and endocytic processes[3]. Syntaxin-12 has predicted SNAP receptor and SNARE binding activities and is implicated in processes including autophagosome assembly, cholesterol transport, and protein recycling[5]. Although not currently a direct target of approved therapeutic drugs, disruptions in its function are relevant to diseases associated with membrane trafficking, such as neurodegeneration and infection[5][3]. *Note on aliases:* Syntaxin-13 (STX13) and syntaxin-14 (STX14) are generally considered distinct but related to syntaxin-12; occasional naming overlap may occur in older or less precise literature but should be recognized as different family members[3]. If structured data is required, ambiguous aliases appearing as STX13/STX14 should be carefully mapped to the canonical target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Syntaxin-12 (STX12).